Anti-Disuse Osteoporosis Activity of a Complex of Calcium-Binding Peptide from Auricularia auricula Protein Hydrolysates.

@article{Qu2019AntiDisuseOA,
  title={Anti-Disuse Osteoporosis Activity of a Complex of Calcium-Binding Peptide from Auricularia auricula Protein Hydrolysates.},
  author={Hang Qu and Juanjuan Yi and Xin Gao and Haitian Zhao and Zhenyu Wang},
  journal={Journal of food science},
  year={2019}
}
Osteoporosis is a common metabolic bone disease that is often seen in bedridden patients and astronauts. Long-term bed rest and nonweight bearing tend to induce disuse osteoporosis. Calcium supplements are commonly used to help treat disuse osteoporosis along with medications, most of which are calcium carbonate based, but they have poor absorption effects. In this study, we prepared a novel Auricularia auricula peptide-calcium complex (AP-Ca) and evaluated its protective effects on disuse… 

Comparative Genomic Analysis of Capsule-Producing Black Yeasts Exophiala dermatitidis and Exophiala spinifera, Potential Agents of Disseminated Mycoses

It is indicated that different virulence profiles existed in the two capsule-producing black yeasts, and the absence of consistent virulence-associated profiles supports the hypothesis that blackYeasts are opportunists rather than primary pathogens.

References

SHOWING 1-10 OF 45 REFERENCES

Effect of anti-osteoporotic agents on the prevention of bone loss in unloaded bone.

The tail-suspension rat model is suitable for the study of disuse osteoporosis under the effects of various therapeutic agents and the preventive effects of raloxifene against bone loss under disuse conditions have been demonstrated using this model.

Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies.

Making analogues of the most potent molecule for developing synthetic series with rational drug design approach could pay rich dividends in menopausal osteoporosis therapy.

Inflammatory and bone turnover markers in relation to PTH and vitamin D status among saudi postmenopausal women with and without osteoporosis.

The present study proved that the pro-inflammatory cytokines accelerate the bone loss in postmenopausal women.

Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension

Trabecular bone in the proximal tibial metaphysis was totally preserved in rats treated with resveratrol before tail-suspension and had a preventive effect against bone loss induced by hindlimb immobilization.

Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma

Measurements of the biochemical markers of bone metabolism may be useful in monitoring myeloma bone disease, and might thus be of use for dose titration of bisphosphonate therapy.

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

Applying results from a murine model of colitis associated bone loss, the constellation of OPG and sRANKL regulation observed in this study raises the possibility that RANKL/OPG may contribute to the development of bone loss in IBD.

Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women

It is concluded that serial determinations of plasma BGP are useful for determination of the effect of oestrogen therapy in groups of patients, and that plasma B GP measured at the time of the menopause indicates what the rate of bone loss will be.